000 | 01950 a2200529 4500 | ||
---|---|---|---|
005 | 20250514030049.0 | ||
264 | 0 | _c20020411 | |
008 | 200204s 0 0 eng d | ||
022 | _a0736-0266 | ||
024 | 7 |
_a10.1016/S0736-0266(01)00083-3 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aGoater, J Jeffrey | |
245 | 0 | 0 |
_aEfficacy of ex vivo OPG gene therapy in preventing wear debris induced osteolysis. _h[electronic resource] |
260 |
_bJournal of orthopaedic research : official publication of the Orthopaedic Research Society _cMar 2002 |
||
300 |
_a169-73 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aAnimals, Newborn |
650 | 0 | 4 | _aCells, Cultured |
650 | 0 | 4 |
_aCulture Media, Conditioned _xpharmacology |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aFibroblasts _xmetabolism |
650 | 0 | 4 | _aGenetic Therapy |
650 | 0 | 4 |
_aGlycoproteins _xbiosynthesis |
650 | 0 | 4 | _aLac Operon |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Inbred CBA |
650 | 0 | 4 |
_aOsteoclasts _xdrug effects |
650 | 0 | 4 |
_aOsteolysis _xprevention & control |
650 | 0 | 4 | _aOsteoprotegerin |
650 | 0 | 4 | _aProstheses and Implants |
650 | 0 | 4 | _aProsthesis Failure |
650 | 0 | 4 | _aRats |
650 | 0 | 4 |
_aReceptors, Cytoplasmic and Nuclear _xbiosynthesis |
650 | 0 | 4 | _aReceptors, Tumor Necrosis Factor |
650 | 0 | 4 |
_aSkull _xenzymology |
650 | 0 | 4 | _aTitanium |
650 | 0 | 4 | _aTransduction, Genetic |
650 | 0 | 4 |
_abeta-Galactosidase _xmetabolism |
700 | 1 | _aO'Keefe, Regis J | |
700 | 1 | _aRosier, Randy N | |
700 | 1 | _aPuzas, J Edward | |
700 | 1 | _aSchwarz, Edward M | |
773 | 0 |
_tJournal of orthopaedic research : official publication of the Orthopaedic Research Society _gvol. 20 _gno. 2 _gp. 169-73 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/S0736-0266(01)00083-3 _zAvailable from publisher's website |
999 |
_c11823500 _d11823500 |